Iovance Biotherapeutics shares owned by Carnegie Capital Asset Management
Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Carnegie Capital Asset Management
from 13F filings
Historical chart of Carnegie Capital Asset Management investment in Iovance Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iovance Biotherapeutics held by Carnegie Capital Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iovance Biotherapeutics by Carnegie Capital Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $80k | 37k | 2.17 |
| 2025-06-30 | $53k | 31k | 1.72 |
| 2024-12-31 | $200k | 27k | 7.40 |
| 2024-09-30 | $254k | 27k | 9.39 |
| 2024-06-30 | $217k | 27k | 8.02 |
| 2024-03-31 | $406k | 27k | 14.82 |
| 2023-12-31 | $223k | 27k | 8.13 |
| 2023-09-30 | $107k | 23k | 4.55 |
| 2023-06-30 | $87k | 12k | 7.04 |
| 2022-06-30 | $631k | 24k | 26.02 |
| 2021-09-30 | $524k | 21k | 24.66 |
| 2021-06-30 | $631k | 24k | 26.02 |
| 2021-03-31 | $761k | 24k | 31.64 |
| 2020-12-31 | $1.2M | 26k | 46.41 |
More positions owned by Carnegie Capital Asset Management
View all positions for Carnegie Capital Asset Management